Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of AFIB will remain same at 0 over the next 2 Weeks and hit $0.00 by Wednesday, April 15, 2026. In that time frame, AFIB's share price is expected to range between $0.00 and $0.00.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Apr 15, 2026 | 0.00 | 0.00 | 0.00 |
| Apr 14, 2026 | 0.00 | 0.00 | 0.00 |
| Apr 13, 2026 | 0.00 | 0.00 | 0.00 |
| Apr 10, 2026 | 0.00 | 0.00 | 0.00 |
| Apr 9, 2026 | 0.00 | 0.00 | 0.00 |
| Apr 8, 2026 | 0.00 | 0.00 | 0.00 |
| Apr 7, 2026 | 0.00 | 0.00 | 0.00 |
| Apr 6, 2026 | 0.00 | 0.00 | 0.00 |
| Apr 3, 2026 | 0.00 | 0.00 | 0.00 |
| Apr 2, 2026 | 0.00 | 0.00 | 0.00 |
AFIB shares remained flat 0 in Thursday, April 2, 2026's trading session, starting and closing at a previous close of $0.00 to move at $0.00. The stock demonstrated notable intraday movement (see AFIB's key stats for a full breakdown), fluctuating between $0.00 and $0.00, a +400.00% trading range. While recent weeks have seen some volatility, AFIB has managed to secure a -50.00% drop over the past 2 weeks. The neutral price movement was accompanied by decreased trading volume, with approximately 451 shares changing hands, 2.68K fewer than the previous session. This amounted to $0.05 in total market activity.
Will AFIB Continue Its Upward Trend?
According to analyst ratings and projections for AFIB, Acutus Medical, Inc. shares are anticipated to increase by +65.22%, potentially reaching $0.00 per share by April 15, 2026. Short-term technical indicators currently suggest a neutral sentiment for AFIB. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 7 positive trading days within the past 30 sessions. Based on the AFIB stock forecast, now is a good time to buy AFIB stock because its current trading price is 0 our predicted value, hinting at a possible . For deeper insights, view our sentiment analysis on AFIB covering social and institutional perspectives.
AFIB Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into AFIB's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 43.52% to 46.45%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 45.57%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 44.69%, maintains a neutral outlook for the long term. Insights into AFIB's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Acutus Medical Short-Term Forecasts
AFIB Forecast For Next 5 Days
Our algorithm anticipates Acutus Medical (AFIB) stock could hit $0.00 by Apr 10, 2026. This represents a - fall from today's price, following a -71.67% change over the past five days.
AFIB Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Acutus Medical, Inc. (AFIB) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $0.00, which would mean a -100.00% decrease from the current price of $0.00. Projections for this period range from a high of $0.00 to a low of $0.00.
AFIB Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Acutus Medical's price over the next three months point to a rise. AFIB stock is expected to peak at $0.10 on Apr 06, 2026 before potentially dipping to $0.01 on Jun 26, 2026. On average, AFIB is likely to trade around $0.06 in the coming 90 days.
Acutus Medical Stock Forecast 2025
Based on our predictive models, Acutus Medical (AFIB) is expected to trade between $0.00 and $0.10 throughout 2026. This would result in an average price of $0.04, potentially offering investors a +39,900.00% return from current levels.
Acutus Medical, Inc. Monthly Forecast 2026–2027
April 2026
According to our latest forecast models, Acutus Medical, Inc. (AFIB) is positioned to show a strong performance in April 2026. The price is predicted to move between $0.04 and $0.10, settling at an average of $0.07. This could translate to a +69,900.00% gain.
May 2026
Based on current market signals, Acutus Medical, Inc. is projected to trend may 2026. We forecast a trading range from $0.03 to $0.09, with a likely average price of $0.06. Investors could expect a potential return of +59,900.00%.
June 2026
Our predictive algorithms indicate Acutus Medical, Inc. stock may see a shift in June 2026. The expected range spans $0.01–$0.07, with an average target of $0.04. This represents a positive outlook and a possible gain of +39,900.00%.
July 2026
Analyzing established trends, Acutus Medical, Inc. looks set to move in July 2026. Projections place the stock between $0.01 and $0.07, averaging around $0.04. This suggests a +39,900.00% gain from current levels.
August 2026
Market indicators suggest Acutus Medical, Inc. could experience notable changes during August 2026. Prices could fluctuate within $0.02 to $0.09, with a midpoint forecast of $0.05. The stock might deliver a +49,900.00% gain.
September 2026
Forecasting for September 2026, models estimate that Acutus Medical, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.01 and $0.06, averaging $0.04. This signals a positive trajectory with potential returns around +39,900.00%.
October 2026
According to our latest forecast models, Acutus Medical, Inc. (AFIB) is positioned to show a strong performance in October 2026. The price is predicted to move between $0.01 and $0.06, settling at an average of $0.04. This could translate to a +39,900.00% gain.
November 2026
Based on current market signals, Acutus Medical, Inc. is projected to trend november 2026. We forecast a trading range from $0.00 to $0.05, with a likely average price of $0.02. Investors could expect a potential return of +19,900.00%.
December 2026
Our predictive algorithms indicate Acutus Medical, Inc. stock may see a shift in December 2026. The expected range spans $0.00–$0.05, with an average target of $0.01. This represents a positive outlook and a possible gain of +9,900.00%.
January 2027
Analyzing established trends, Acutus Medical, Inc. looks set to move in January 2027. Projections place the stock between $0.00 and $0.06, averaging around $0.03. This suggests a +29,900.00% gain from current levels.
February 2027
Market indicators suggest Acutus Medical, Inc. could experience notable changes during February 2027. Prices could fluctuate within $0.00 to $0.06, with a midpoint forecast of $0.03. The stock might deliver a +29,900.00% gain.
March 2027
Forecasting for March 2027, models estimate that Acutus Medical, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.05, averaging $0.02. This signals a positive trajectory with potential returns around +19,900.00%.
April 2027
According to our latest forecast models, Acutus Medical, Inc. (AFIB) is positioned to show a strong performance in April 2027. The price is predicted to move between $0.00 and $0.04, settling at an average of $0.02. This could translate to a +19,900.00% gain.
AFIB's history of dividends and stock splits also plays a role in long-term investor confidence.